DK0788349T3 - Selegilin-holdigt liposompræparat - Google Patents

Selegilin-holdigt liposompræparat

Info

Publication number
DK0788349T3
DK0788349T3 DK95935530T DK95935530T DK0788349T3 DK 0788349 T3 DK0788349 T3 DK 0788349T3 DK 95935530 T DK95935530 T DK 95935530T DK 95935530 T DK95935530 T DK 95935530T DK 0788349 T3 DK0788349 T3 DK 0788349T3
Authority
DK
Denmark
Prior art keywords
weight
pct
liposomic
composition
selegilin
Prior art date
Application number
DK95935530T
Other languages
Danish (da)
English (en)
Inventor
Jozsef Gaal
Gyula Szebeni
Tamasne Marmarosi
Kalman Magyar
Jozsef Lengyel
Istvan Szatmari
Gnes Turi
Gabor Szekacs
Michael Mezei
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Application granted granted Critical
Publication of DK0788349T3 publication Critical patent/DK0788349T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Detergent Compositions (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95935530T 1994-10-24 1995-10-20 Selegilin-holdigt liposompræparat DK0788349T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9403073A HU223475B1 (hu) 1994-10-24 1994-10-24 Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására
PCT/HU1995/000052 WO1996012472A1 (en) 1994-10-24 1995-10-20 Liposome composition containing selegilin

Publications (1)

Publication Number Publication Date
DK0788349T3 true DK0788349T3 (da) 2001-11-26

Family

ID=10985697

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95935530T DK0788349T3 (da) 1994-10-24 1995-10-20 Selegilin-holdigt liposompræparat

Country Status (30)

Country Link
US (1) US5888536A (de)
EP (1) EP0788349B1 (de)
JP (1) JPH10507749A (de)
KR (1) KR100313149B1 (de)
CN (1) CN1084186C (de)
AT (1) ATE205387T1 (de)
AU (1) AU691348B2 (de)
BG (1) BG63327B1 (de)
BR (1) BR9509517A (de)
CA (1) CA2203513C (de)
CZ (1) CZ287349B6 (de)
DE (1) DE69522701T2 (de)
DK (1) DK0788349T3 (de)
EE (1) EE03418B1 (de)
ES (1) ES2160718T3 (de)
FI (1) FI971743A (de)
HU (1) HU223475B1 (de)
IL (1) IL115754A (de)
NO (1) NO316354B1 (de)
NZ (1) NZ294660A (de)
PL (1) PL183104B1 (de)
PT (1) PT788349E (de)
RO (1) RO116768B1 (de)
RU (1) RU2159106C2 (de)
SK (1) SK281599B6 (de)
TW (1) TW412420B (de)
UA (1) UA44289C2 (de)
WO (1) WO1996012472A1 (de)
YU (1) YU49313B (de)
ZA (1) ZA958999B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2472499A (en) * 1998-01-27 1999-08-09 Thomas N. Thomas Methods of treatment using mao-a and mao-b inhibitors such as l-deprenyl
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
CA2536393A1 (en) * 2003-09-09 2005-06-16 Gilead Sciences, Inc. Use of liposomes which are small unilamellar vesicles for the removal of an entity from a biological sample
EP1848541A4 (de) * 2005-02-07 2013-01-16 Pharmalight Inc Verfahren und vorrichtung zur ophthalmischen verabreichung von pharmazeutischen wirksstoffen
CN1813679A (zh) * 2005-11-30 2006-08-09 上海医药(集团)有限公司 一种紫杉烷脂质体冻干组合物及其制备方法
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP5623102B2 (ja) * 2010-03-12 2014-11-12 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
JP5693026B2 (ja) * 2010-03-12 2015-04-01 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
RU2678433C2 (ru) 2012-05-10 2019-01-29 Пейнреформ Лтд. Депо-составы гидрофобного активного ингредиента и способы их получения
AU2015326378B2 (en) * 2014-09-29 2021-01-21 Council Of Scientific & Industrial Research A formulation useful for delivery of neuro protecting agent
EP3600435B1 (de) * 2017-03-23 2024-03-20 Lipid Systems sp. z.o.o. Hochwirksame verkapselung hydrophiler verbindungen in unilamellaren liposomen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588887A5 (de) * 1974-07-19 1977-06-15 Battelle Memorial Institute
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
FR2713087B1 (fr) * 1993-11-30 1996-02-23 Saurat Jean Hilaire Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.

Also Published As

Publication number Publication date
EE03418B1 (et) 2001-06-15
ZA958999B (en) 1996-05-15
PL183104B1 (pl) 2002-05-31
CZ287349B6 (en) 2000-10-11
CZ114797A3 (en) 1997-10-15
PT788349E (pt) 2001-12-28
HUT76053A (en) 1997-06-30
WO1996012472A1 (en) 1996-05-02
FI971743A0 (fi) 1997-04-23
EP0788349A1 (de) 1997-08-13
FI971743A (fi) 1997-04-23
YU67195A (sh) 1998-07-10
KR970706797A (ko) 1997-12-01
RU2159106C2 (ru) 2000-11-20
NO971870D0 (no) 1997-04-23
TW412420B (en) 2000-11-21
IL115754A (en) 1999-07-14
SK51797A3 (en) 1997-11-05
CN1163563A (zh) 1997-10-29
YU49313B (sh) 2005-06-10
EE9700102A (et) 1997-10-15
UA44289C2 (uk) 2002-02-15
SK281599B6 (sk) 2001-05-10
DE69522701D1 (de) 2001-10-18
NZ294660A (en) 1998-05-27
AU3751895A (en) 1996-05-15
KR100313149B1 (ko) 2002-02-19
BR9509517A (pt) 1997-12-30
US5888536A (en) 1999-03-30
EP0788349B1 (de) 2001-09-12
PL319875A1 (en) 1997-09-01
AU691348B2 (en) 1998-05-14
BG63327B1 (bg) 2001-10-31
CN1084186C (zh) 2002-05-08
DE69522701T2 (de) 2002-07-11
NO316354B1 (no) 2004-01-19
MX9703019A (es) 1997-10-31
HU9403073D0 (en) 1994-12-28
CA2203513C (en) 2001-10-09
NO971870L (no) 1997-06-24
JPH10507749A (ja) 1998-07-28
IL115754A0 (en) 1996-01-19
ES2160718T3 (es) 2001-11-16
ATE205387T1 (de) 2001-09-15
RO116768B1 (ro) 2001-06-29
HU223475B1 (hu) 2004-07-28
CA2203513A1 (en) 1996-05-02
BG101432A (en) 1997-12-30

Similar Documents

Publication Publication Date Title
ES2301189T3 (es) Agentes de limpieza antimicrobianos.
NO974023D0 (no) Topisk appliserbart farmasöytisk preparat, fremgangsmåte for dets fremstilling og anvendelse derav
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
JP2002003364A (ja) 点眼剤、眼科用組成物及び吸着抑制方法
DK0788349T3 (da) Selegilin-holdigt liposompræparat
JP2011116690A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP3142842B1 (ja) 眼科用組成物及びソフトコンタクトレンズへの吸着抑制方法
JP2018188486A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP3175742B1 (ja) コンタクトレンズ用眼科用組成物
JP2011111441A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP5681472B2 (ja) 眼科用組成物
JP2011098961A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
TR200100897T2 (tr) Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri.
JP5650864B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2005075735A (ja) オキシメタゾリン含有組成物
JP2002104971A (ja) 眼科用組成物
JP2015028090A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2001187741A (ja) 皮膚外用医薬組成物
JP2002338476A (ja) 腎透析に伴う痒みの予防治療剤
JPH11180872A (ja) 骨代謝改善剤